1-9 of 9
Ji Xu
Close
Sort by
Journal Articles

Activating NOTCH1 Mutations Alter T-ALL Chemosensitivity By PREX2-AKT Pathway

Hui Yu, MD, PhD, Yuxin DU, MD, M.S., Ji Xu, MD, PhD, Zhenchang Sun, MD, PhD, Xiaorui Fu, MD, PhD, Ken H. Young, MD, PhD, Mingzhi Zhang, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 46–47.
https://doi.org/10.1182/blood-2020-138665
Published: 2020
Journal Articles

Correlation Analysis Between Serum Lactate Dehydrogenase and Prognosis in Old New Diagnosed Multiple Myeloma Patients

Yahui Yuan, Yan Gu, Xiaoyan Qu, PhD, Qinglin Shi, Hua Bai, Ji Xu, Jiadai Xu, Jianyong Li, Lijuan Chen, PhD
Journal: Blood
Blood (2016) 128 (22): 5637.
https://doi.org/10.1182/blood.V128.22.5637.5637
Published: 2016
Journal Articles

Distinct IGHV Repertoire Features In Chinese Chronic Lymphocytic Leukemia Patients

Yi Xia, MD., Wei Xu, MD, PhD, Lei Fan, MD, PhD, Chun Qiao, Li Wang, MD., Ji Xu, MD., Man Wang, MD., Jian-Yong Li, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 5279.
https://doi.org/10.1182/blood.V122.21.5279.5279
Published: 2013
Journal Articles

Interim Results From a Phase II Study Of Non-Anthracycline Combination Of Oxaliplatin-Gemcitabine Plus Rituximab (R-GemOx) As First-Line Treatment In Elderly Patients With Diffuse Large B-Cell Lymphoma

Lei Fan, MD, PhD, Li Wang, MD., Ji Xu, MD., Run Zhang, M.D., Yuqiong Yang, M.D., Dongping Huang, Yunfeng Shen, Min Zhou, Liang Yu, Zhihong Zhang, Wei Xu, MD, PhD, Jianyong Li, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 3034.
https://doi.org/10.1182/blood.V122.21.3034.3034
Published: 2013
Journal Articles

Clinical Study Of Dose-Adjusted EPOCH Regimen For Non-Hodgkin's Lymphoma With Hemophagocytic Lymphohistiocytosis: Preliminary Results Of An Ongoing Phase II Study

Wei Xu, MD, PhD, Lei Fan, MD, PhD, Li Wang, MD., Ji Xu, MD., Run Zhang, M.D., Yuqiong Yang, M.D., Dongping Huang, Yunfeng Shen, Min Zhou, Liang Yu, Zhihong Zhang, Jianyong Li, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 4360.
https://doi.org/10.1182/blood.V122.21.4360.4360
Published: 2013
Journal Articles

Circulating microRNA 483-5p in multiple myeloma as a novel biomarker for diagnosis and predicting survival

Qu Xiaoyan, Min Zhao, Shuang Wu, Yu Wenjun, Xu Jiaren, Ji Xu, Jianyong Li, MD, PhD, Chen Lijuan, PhD , MD
Journal: Blood
Blood (2013) 122 (21): 5343.
https://doi.org/10.1182/blood.V122.21.5343.5343
Published: 2013
Journal Articles

A Splicing Variant of MDM4 Overexpression Plays an Indicator of p53 Aberrations and Marks a Potential Therapeutic Target in Chronic Lymphocytic Leukemia

Wei Xu, Ling Liu, Lei Fan, M.D., Ph.D., Li Wang, M.D., Run Zhang, M.D., Ji Xu, M.D.
Journal: Blood
Blood (2012) 120 (21): 4564.
https://doi.org/10.1182/blood.V120.21.4564.4564
Published: 2012
Journal Articles

Clinical Phase II Study of a Non-Anthracycline-Based Immunochemotherapy Regimen(R-GemOx) As First-Line Treatment in Elderly Patients with Diffuse Large B-Cell Lymphoma

Lei Fan, M.D., Ph.D., Li Wang, M.D., Ji Xu, M.D., Run Zhang, M.D., Rong Wang, Wei Xu, MD, PhD, Jianyong Li, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 3667.
https://doi.org/10.1182/blood.V120.21.3667.3667
Published: 2012
Journal Articles

Analysis of Clinical Features and Survival in 42 Cases of Acute Monocytic Leukemia

Hongxia Qiu, Hanxin Wu, Songwen Ju, Wei Xu, Ji Xu, Xin Lv, Jinzhang Shao, Ri Zhang
Journal: Blood
Blood (2008) 112 (11): 3992.
https://doi.org/10.1182/blood.V112.11.3992.3992
Published: 2008